Jeffrey Bode - Curriculum Vitae#

Education

• 2001 Doctor of Natural Science in Chemistry (Dr. rer. nat.), Swiss Federal Institute of Technology (ETH), Zürich, Switzerland
  
• 1996 Bachelor of Arts in Philosophy, Trinity University, San Antonio, Texas, USA

Professional Experience

• 1/2010 Professor of Synthetic Organic Chemistry, Swiss Federal Institute of Technology (ETH), Zürich, Switzerland
  
• 6/2007 - 12/2009 Associate and Full Professor of Chemistry, University of Pennsylvania
  
• 7/2003 - 6/2007 Assistant Professor of Chemistry and Biochemistry, University of California, Santa Barbara
  
• 2001 - 2003 Postdoctoral Research Fellow, Tokyo Institute of Technology, Tokyo, Japan

Other Appointments

• 2026 Institute Director, Laboratory of Organic Chemistry, ETH Zürich
  
• 11/2022 Co-Founder, Scientific Advisor and Board Observer, Serac Biotherapeutics
  
• 12/2019 Director of Studies, Biochemistry and Chemical Biology (BCB), ETH Zürich
  
• 7/2019 Research Council Member, Swiss National Science Foundation
  
• 6/2019 Organizer and Lead, Chemical Protein Synthesis Meeting (postponed to 2024)
  
• 12/2017 co-Founder, Bright Peak Therapeutics (Board Member 2017 - 2020)
  
• 9/2016 co-Founder, Synple Chem AG (Board Member 2016–2020)
  
• 9/2016 Founder and Steering Committee Chair, Molecular and Biomolecular Analytical Services (MoBiAS), D-CHAB, ETH Zürich
  
• 2013 - 2016 Institute Director, Laboratory of Organic Chemistry, ETH Zürich
  
• 4/2013 Principal Investigator, WPI-Institute for Transformative Biomolecules (ITbM), Nagoya University, Nagoya, JAPAN
  
• 1/2011 - 12/2022 Consultant, Novartis Global Discovery Chemistry (Basel, Cambridge, Shanghai)
  
• 1/2010 - 12/2021 Board Member, Bioblock, Inc. (San Diego, Budapest)

Editorial Positions

• 1/2016 - 12/2021 co-Editor-in-Chief, Helvetica Chimica Acta (with Prof. Dr. Christophe Coperet)
  
• 9/2014 Executive Editor, Encyclopedia of Reagents for Organic Synthesis
  
• 11/2009 - 1/2016 Associate Editor: Amino Acids
  
• 1/2009 - 1/2015 Editorial Board: Organic and Biomolecular Chemistry (Chair, 01/2011–01/2015)
  
• various Editorial Advisory Board: ACS Central Science, Organic Letters, Chemical Science, Tetrahedron, Tetrahedron Letters, The Chemical Record

Outreach Program for High Schools Students

PhD Graduates: 60 PhD Graduates
Postdoctoral Scholars Supervised: >50 Postdocs Supervised

Publications: >230 publications

Invited Seminars: >400 invited seminars

Patents: >20 patents

co-Founder: Synple Chem (Zürich, CH, 2016, 6 employees), Bright Peak Therapeutics (Basel, CH and San Diego, USA, 2017, >40 employees), Serac Biosciences (Basel, CH, 2022, 20 employees)